Categories
Change Password!
Reset Password!
Approval of self-administered flu vaccine paves the way for greater accessibility and flexibility in seasonal flu prevention, offering families a convenient option and demonstrating a commitment to advancing public health.
Flu protection is now at your fingertips!
On September 20, 2024, the Food and Drug Administration (FDA) approved an intranasal flu vaccine for self- or caregiver administration, marking a major advancement in flu prevention. This vaccine shields against influenza A and B viruses and is approved for those aged 2 to 49. Earlier, it was approved in 2003 for ages 5 and up, but its use was expanded in 2007 to include younger children aged 2 through 5. This latest approval makes it the first flu vaccine that doesn't require administration by a healthcare professional. The FDA's Center for Biologics Evaluation and Research highlighted this approval as a significant step in providing a convenient option for the annual flu vaccine, essential for safeguarding against influenza.
Influenza is an infectious respiratory illness that peaks in the U.S. during fall and winter, causing symptoms like fever, cough, and fatigue. It poses serious risks for high-risk groups, leading to hospitalization and death. The Centers for Disease Control and Prevention (CDC) reports 9.3 million to 41 million illnesses annually, with numerous FDA-approved vaccines available each season to help prevent the flu. This flu vaccine is administered via an intranasal route containing a diluted form of live influenza virus strains. It has been safely used for years and can now be administered at home by recipients or caregivers over 18, although a prescription is still required.
Side effects may comprise mild symptoms, for example, fever in young children, runny nose, congestion, and pharyngitis (sore throat) in adults. The vaccine will be available online, with pharmacies managing prescriptions and shipping to eligible individuals for at-home usage. It is important to use the instructions to ensure proper storage, administration, and disposal of this flu vaccine. Caregivers must administer it to pediatric patients (2 to 17 years old).
FDA
FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver-Administration
Comments (0)